N7D.USJSL=D1N/V!Y/L!15O{'_4
SYSTEM PROCESSING...
N7D.USJSL=D1N/V!Y/L!15O{'_4
SYSTEM PROCESSING...
Posted: 2025-04-09 15:33:35 UTC
This article contains some claims that remain unverified. While much of the content may be accurate, exercise care when relying on this information.
This article contains some claims that remain unverified. While much of the content may be accurate, exercise care when relying on this information.
Status
Last Updated
2025-04-09 15:38:57 UTC
Verified By
Rollup News
Monoclonal antibodies show promise for treating infectious diseases in low- and middle-income countries (LMICs), but their high costs and slow production limit accessibility. Chun Chen suggests strategies to improve efficiency.
Potential of monoclonal antibodies for treating infectious diseases in LMICs
High costs and slow production hinder access
Strategies to improve efficiency: scale up, scale out, and scale by time
High costs of monoclonal antibodies
Slow production of monoclonal antibodies
Limited access in LMICs